Interim report Q4 2022

BioArctic AB will publish the company’s fourth quarter report for October – December 2022 on Friday, February 3, 2022, at 08:00 a.m. CET.

Alzheimer’s disease

Halting the disease progression would lead to great benefits to patients, families and caregivers.

Parkinson’s disease

The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.

Neurodegenerative disorders

BioArctic is committed to help people with neurodegenerative disorders

Proud partner of: